ProfileGDS4718 / 230971_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 55% 52% 49% 56% 50% 40% 46% 60% 53% 55% 51% 46% 50% 42% 46% 51% 50% 46% 44% 52% 61% 43% 54% 49% 48% 42% 46% 47% 59% 45% 44% 40% 60% 51% 45% 36% 42% 55% 54% 45% 56% 46% 38% 46% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.8367955
GSM549102patient 115, normal, homogenized [OPG study]5.6590152
GSM549104patient 119, normal, homogenized [OPG study]5.4477849
GSM549108patient 138, normal, homogenized [OPG study]5.8924456
GSM549119patient 077, normal, homogenized [OPG study]5.5244150
GSM549133patient 032, cancer, homogenized [OPG study]4.9507240
GSM549139patient 042, cancer, homogenized [OPG study]5.2510146
GSM549099patient 107, normal, homogenized [OPG study]6.1232660
GSM549109patient 139, normal, homogenized [OPG study]5.6988553
GSM549110patient 046, normal, homogenized [OPG study]5.779155
GSM549114patient 063, normal, homogenized [OPG study]5.5277551
GSM549122patient 082, normal, homogenized [OPG study]5.3099746
GSM549134patient 033, cancer, homogenized [OPG study]5.4913950
GSM549136patient 036, cancer, homogenized [OPG study]5.0502542
GSM549140patient 044, cancer, homogenized [OPG study]5.2563446
GSM549111patient 047, normal, homogenized [OPG study]5.540751
GSM549113patient 057, normal, homogenized [OPG study]5.4722650
GSM549132patient 031, cancer, homogenized [OPG study]5.2837446
GSM549137patient 038, cancer, homogenized [OPG study]5.188744
GSM549142patient 047, cancer, homogenized [OPG study]5.7419452
GSM549100patient 110, normal, homogenized [OPG study]6.1496861
GSM549107patient 135, normal, homogenized [OPG study]5.0857143
GSM549115patient 068, normal, homogenized [OPG study]5.6888454
GSM549116patient 072, normal, homogenized [OPG study]5.4149249
GSM549120patient 078, normal, homogenized [OPG study]5.4029648
GSM549131patient 030, cancer, homogenized [OPG study]5.0072342
GSM549118patient 074, normal, homogenized [OPG study]5.3062846
GSM549129patient 027, cancer, homogenized [OPG study]5.3508747
GSM549123patient 088, normal, homogenized [OPG study]6.0441559
GSM549124patient 006, cancer, homogenized [OPG study]5.2762345
GSM549126patient 015, cancer, homogenized [OPG study]5.1624544
GSM549128patient 025, cancer, homogenized [OPG study]4.9477340
GSM549103patient 117, normal, homogenized [OPG study]6.1436360
GSM549117patient 073, normal, homogenized [OPG study]5.5423951
GSM549138patient 041, cancer, homogenized [OPG study]5.2522445
GSM549141patient 045, cancer, homogenized [OPG study]4.7361236
GSM549130patient 028, cancer, homogenized [OPG study]5.1099142
GSM549101patient 111, normal, homogenized [OPG study]5.8476655
GSM549105patient 128, normal, homogenized [OPG study]5.7741754
GSM549106patient 134, normal, homogenized [OPG study]5.1839945
GSM549112patient 048, normal, homogenized [OPG study]5.8902456
GSM549125patient 011, cancer, homogenized [OPG study]5.296546
GSM549127patient 024, cancer, homogenized [OPG study]4.9129538
GSM549135patient 035, cancer, homogenized [OPG study]5.2561846